Applied Therapeutics (APLT) said it appointed John Johnson as executive chairman and Chief Financial Officer Les Funtleyder as interim chief executive, effective immediately.
Johnson and Funtleyder succeed Shoshana Shendelman, who has stepped down as chair and CEO, the company said.
Funtleyder will continue to serve as CFO while taking on the responsibilities of interim CEO with support from the finance team, the company added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.